Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: A children's oncology group phase 2 study

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 1, 2013, Pages

  Bradley, Kristin A ^a   Zhou, Tianni ^b   McNall Knapp, Rene Y ^c   Jakacki, Regina I ^d   Levy, Adam S ^e   Vezina, Gilbert ^f   Pollack, Ian F ^d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOSE IRRADIATION; FRACTIONATED RADIATION; INVOLVED-FIELD RADIATION THERAPY; LYMPHOPENIA; OVERALL SURVIVAL; PEDIATRIC PATIENTS; RADIOSENSITIZERS; TOTAL DOSE;

GADOLINIUM; RADIOTHERAPY;

TUMORS;

GADOLINIUM TEXAPHYRIN;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLERGY; ARTICLE; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DRUG EFFICACY; EVENT FREE SURVIVAL; FEMALE; HEADACHE; HUMAN; HYPERTENSION; HYPERTRANSAMINASEMIA; LEUKOPENIA; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; OVERALL SURVIVAL; PAIN; PHASE 2 CLINICAL TRIAL; PONTINE GLIOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SCHOOL CHILD; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; BRAIN STEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOMA; HUMANS; HYPERTENSION; INFANT; INFUSIONS, INTRAVENOUS; LIVER; LYMPHOPENIA; MALE; METALLOPORPHYRINS; PONS; RADIATION-SENSITIZING AGENTS;

EID: 84871373647     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.09.004     Document Type: Article

References (30)

1. D. Hargrave, U. Bartels, and E. Bouffet Diffuse brainstem glioma in children: critical review of clinical trials Lancet Oncol 7 2006 241 248 (Pubitemid 43286454)
2. M.A. Smith, B. Freidlin, and L.A. Ries Trends in reported incidence of primary malignant brain tumors in children in the United States J Natl Cancer Inst 90 1998 1269 1277 (Pubitemid 28433471)
3. F. Laigle-Donadey, F. Doz, and J.Y. Delattre Brainstem gliomas in children and adults Curr Opin Oncol 20 2008 662 667
4. C.R. Freeman, J.P. Krischer, and R.A. Sanford Final results of a study of escalating doses of hyperfractionated radiation therapy in brain stem tumors in children: a Pediatric Oncology Group study Int J Radiat Oncol Biol Phys 27 1993 197 206 (Pubitemid 23304443)
5. L.R. Mandell, R. Kadota, and C. Freeman There is no role for hyperfractionated radiation therapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy Int J Radiat Oncol Biol Phys 43 1999 959 964 (Pubitemid 29144779)
6. C.R. Freeman, J. Krischer, and R.A. Sanford Hyperfractionated radiotherapy in brain stem tumors: results of a Pediatric Oncology Group study Int J Radiat Oncol Biol Phys 15 1988 311 318
7. R.J. Packer, J.M. Boyett, and R.A. Zimmerman Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial Cancer 72 1993 1414 1421 (Pubitemid 23225017)
8. A.W. Walter, A. Gajjar, and J.S. Ochs Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study Med Pediatr Oncol 30 1998 28 33 (Pubitemid 128765909)
9. A. Michalski, E. Bouffet, and R.E. Taylor The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma J Neurooncol 100 2010 81 88
10. J. Allen, J. Siffert, and B. Donahue A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas Cancer 86 1999 1064 1069 (Pubitemid 29439863)
11. K.J. Marcus, S.C. Dutton, and P. Barnes A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma Int J Radiat Oncol Biol Phys 55 2003 1182 1185 (Pubitemid 36338282)
12. V. Bernier-Chastagner, J. Grill, and F. Doz Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study Cancer 104 2005 2792 2797 (Pubitemid 41798290)
13. S.I. Hashemy, J.S. Ungerstedt, and F. Zahedi Avval Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase J Biol Chem 281 2006 10691 10697 (Pubitemid 43855490)
14. P.S. Lecane, M.W. Karaman, and M. Sirisawad Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines Cancer Res 65 2005 11676 11688 (Pubitemid 41821728)
15. D. Magda, P. Lecane, and R.A. Miller Motexafin gadolinium disrupts zinc metabolism in human cancer cell lines Cancer Res 65 2005 3837 3845 (Pubitemid 40616364)
16. R.A. Miller, K. Woodburn, and Q. Fan In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer Int J Radiat Oncol Biol Phys 45 1999 981 989 (Pubitemid 29525463)
17. S. Xu, K. Zakian, and H. Thaler Effects of motexafin gadolinium on tumor metabolism and radiation sensitivity Int J Radiat Oncol Biol Phys 49 2001 1381 1390 (Pubitemid 32294318)
18. K.A. Bradley, I.F. Pollack, and J.M. Reid Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study Neurooncol 10 2008 752 758
19. M.T. Jennings, R. Sposto, and J.M. Boyett Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group J Clin Oncol 20 2002 3431 3437
20. R.J. Packer, J.M. Boyett, and R.A. Zimmerman Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial Cancer 74 1994 1827 1834 (Pubitemid 24301840)
21. D.N. Korones, P.G. Fisher, and C. Kretschmar Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study Pediatr Blood Cancer 50 2008 227 230
22. K.J. Cohen, R.L. Heideman, and T. Zhou Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group Neurooncol 13 2011 410 416
23. D.A. Haas-Kogan, A. Banerjee, and M. Kocak Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma Neurooncol 10 2008 341 347
24. A. Broniscer, J.N. Baker, and M. Tagen Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma J Clin Oncol 28 2010 4762 4768
25. I.F. Pollack, R.I. Jakacki, and S.M. Blaney Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report Neurooncol 9 2007 145 160 (Pubitemid 46580316)
26. H.C. Ugur, N. Ramakrishna, and L. Bello Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model J Neurooncol 83 2007 267 275 (Pubitemid 46952237)
27. P. Chinnaiyan, G. Vallabhaneni, and E. Armstrong Modulation of radiation response by histone deacetylase inhibition Int J Radiat Oncol Biol Phys 62 2005 223 229 (Pubitemid 40591946)
28. D. Yin, J.M. Ong, and J. Hu Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo Clin Cancer Res 13 2007 1045 1052 (Pubitemid 46340384)
29. I.Y. Eyupoglu, E. Hahnen, and R. Buslei Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo J Neurochem 93 2005 992 999 (Pubitemid 40695758)
30. M. Zarghooni, U. Bartels, and E. Lee Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets J Clin Oncol 28 2010 1337 1344